Biogen (BIIB) EBITDA margin US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA margin, % | ? | 52.3% | 35.8% | 33.3% | 26.4% | 26.4% | 25.0% | ||
Changes by years, y/y, % | +1pp | -17pp | -2pp | -7pp | +0pp | -12.3% |
Biogen. EBITDA margin, %
Biogen. EBITDA margin, changes, pp
Biogen (BIIB) EBITDA margin US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
EBITDA margin, % | ? | 23.4% | 28.9% | 14.7% | 26.1% | 31.5% | 25.0% | |
Changes by years, y/y, % | -6pp | -11pp | -24pp | +6pp | +8pp | |||
Changes by quarters, q/q, % | +3pp | +5pp | -14pp | +11pp | +5pp |